NITD-304

N/A

Report date: 2023/09/13 09:14:18
NME

Base Information

Drug NameNITD-304
Drug Alias NameNITD-304
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMycobacterial membrane protein large 3 inhibitors
TargetsMycobacterial membrane protein large 3
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A